Microcrystalline cellulose Sub12626mig 658,14mg clinical trials

Efficacy, safety, and dose-response of a Live Biotherapeutic Product (BGY-1601-VT, vaginal tablet) as a first-line monotherapy in women with acute vaginal infection: a randomized, double-blind, placebo-controlled study

This study is testing a new vaginal tablet to treat common vaginal infections in women. It aims to see how well it works, how safe it is, and the best dose to use. We're comparing it to a dummy tablet to find the most effective treatment.